Nuritas
PrivateLast Round
Series C
Dec 20, 2024
Total Funding Raised
$146.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuritas is a biotechnology company that utilizes a platform combining artificial intelligence and genomics to discover and unlock natural bioactive peptides for use in dietary supplements, functional foods, and cosmetics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuritas Comparables
Compare Nuritas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shiru | 87% | |
| Brightseed | 83% | |
| Protera | 81% |
Nuritas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 20, 2024 | ||||
| Series B | Nov 11, 2021 | ||||
| Debt | Nov 29, 2018 | ||||
| Series A | Dec 20, 2017 | ||||
| Seed | Dec 7, 2016 | ||||
Seed | Oct 26, 2015 |
Key People
Founding team and executive leadership
Nuritas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cultivian Sandbox Ventures | Series B, Series A |
| Grosvenor Food & AgTech | Series C, Series B |
| McWin Capital Partners | Series C |
| European Investment Bank Group | Debt |
| M&G Investments | Series C |
| Cleveland Avenue | Series B |
| Clay Capital | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 36% MoM, from 12.4K to 16.9K.
- May 5, 2026
Exhibiting at Vitafoods Europe 2026 in Barcelona.
Recent news
Latest coverage and updates
- hiresSep 10, 2026
Nuritas hired Kees Kruythoff as Chair of Board of Directors on Sep 10th '26.
- is_developingJul 24, 2026
Nuritas Ltd is developing peptide ingredients for health, nutrition, and skin longevity..
Nuritas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nuritas's valuation, stock price, and market status.
Is Nuritas a public or private company?
Nuritas is a private company.
What is the current stock price of Nuritas?
Nuritas is a private company, so its shares have no public market price. Caplight tracks Nuritas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuritas worth (valuation)?
Valuation information for Nuritas is not publicly available.
Can I buy Nuritas stock?
Nuritas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuritas's last funding round?
Nuritas's most recent funding round was Series C on December 20, 2024.
Who are the main investors in Nuritas?
Key investors in Nuritas include Cultivian Sandbox Ventures, M&G Investments, Cleveland Avenue, Clay Capital.
Will Nuritas IPO soon?
No public IPO plans have been announced for Nuritas.
How can I track Nuritas secondary market activity?
Caplight tracks bids, offers, and trades in Nuritas's shares on secondary markets.